Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Gadolinium(III)-gold nanorods for MRI and photoacoustic imaging dual-modality detection of macrophages in atherosclerotic inflammation.

Qin H, Zhou T, Yang S, Chen Q, Xing D.

Nanomedicine (Lond). 2013 Oct;8(10):1611-24. doi: 10.2217/nnm.12.168. Epub 2013 Jan 25.

PMID:
23351094
2.

Diagnostic Magnetic Resonance Imaging of Atherosclerosis in Apolipoprotein E Knockout Mouse Model Using Macrophage-Targeted Gadolinium-Containing Synthetic Lipopeptide Nanoparticles.

Shen ZT, Zheng S, Gounis MJ, Sigalov AB.

PLoS One. 2015 Nov 16;10(11):e0143453. doi: 10.1371/journal.pone.0143453. eCollection 2015.

3.

Incorporation of an apoE-derived lipopeptide in high-density lipoprotein MRI contrast agents for enhanced imaging of macrophages in atherosclerosis.

Chen W, Vucic E, Leupold E, Mulder WJ, Cormode DP, Briley-Saebo KC, Barazza A, Fisher EA, Dathe M, Fayad ZA.

Contrast Media Mol Imaging. 2008 Nov-Dec;3(6):233-42. doi: 10.1002/cmmi.257.

PMID:
19072768
4.

Molecular and cellular targets of the MRI contrast agent P947 for atherosclerosis imaging.

Ouimet T, Lancelot E, Hyafil F, Rienzo M, Deux F, Lemaître M, Duquesnoy S, Garot J, Roques BP, Michel JB, Corot C, Ballet S.

Mol Pharm. 2012 Apr 2;9(4):850-61. doi: 10.1021/mp2003863. Epub 2012 Mar 8.

PMID:
22352457
5.

Nature-inspired nanoformulations for contrast-enhanced in vivo MR imaging of macrophages.

Sigalov AB.

Contrast Media Mol Imaging. 2014 Sep-Oct;9(5):372-82. doi: 10.1002/cmmi.1587. Epub 2014 Apr 14.

6.

Plasmonic intravascular photoacoustic imaging for detection of macrophages in atherosclerotic plaques.

Wang B, Yantsen E, Larson T, Karpiouk AB, Sethuraman S, Su JL, Sokolov K, Emelianov SY.

Nano Lett. 2009 Jun;9(6):2212-7. doi: 10.1021/nl801852e.

PMID:
18844426
7.

Detection of vulnerable atherosclerosis plaques with a dual-modal single-photon-emission computed tomography/magnetic resonance imaging probe targeting apoptotic macrophages.

Cheng D, Li X, Zhang C, Tan H, Wang C, Pang L, Shi H.

ACS Appl Mater Interfaces. 2015 Feb 4;7(4):2847-55. doi: 10.1021/am508118x. Epub 2015 Jan 20.

PMID:
25569777
8.

Enzyme-sensitive magnetic resonance imaging targeting myeloperoxidase identifies active inflammation in experimental rabbit atherosclerotic plaques.

Ronald JA, Chen JW, Chen Y, Hamilton AM, Rodriguez E, Reynolds F, Hegele RA, Rogers KA, Querol M, Bogdanov A, Weissleder R, Rutt BK.

Circulation. 2009 Aug 18;120(7):592-9. doi: 10.1161/CIRCULATIONAHA.108.813998. Epub 2009 Aug 3.

9.

Use of contrast enhancement and high-resolution 3D black-blood MRI to identify inflammation in atherosclerosis.

Hur J, Park J, Kim YJ, Lee HJ, Shim HS, Choe KO, Choi BW.

JACC Cardiovasc Imaging. 2010 Nov;3(11):1127-35. doi: 10.1016/j.jcmg.2010.08.012.

10.

Emerging engineered magnetic nanoparticulate probes for targeted MRI of atherosclerotic plaque macrophages.

Kanwar RK, Chaudhary R, Tsuzuki T, Kanwar JR.

Nanomedicine (Lond). 2012 May;7(5):735-49. doi: 10.2217/nnm.12.46. Review.

PMID:
22630154
11.

Gold nanorods as absorption contrast agents for the noninvasive detection of arterial vascular disorders based on diffusion reflection measurements.

Ankri R, Leshem-Lev D, Fixler D, Popovtzer R, Motiei M, Kornowski R, Hochhauser E, Lev EI.

Nano Lett. 2014 May 14;14(5):2681-7. doi: 10.1021/nl500573d. Epub 2014 Apr 8.

PMID:
24697682
12.

Inflammation-targeted gold nanorods for intravascular photoacoustic imaging detection of matrix metalloproteinase-2 (MMP2) in atherosclerotic plaques.

Qin H, Zhao Y, Zhang J, Pan X, Yang S, Xing D.

Nanomedicine. 2016 Oct;12(7):1765-1774. doi: 10.1016/j.nano.2016.02.016. Epub 2016 Mar 22.

PMID:
27013129
13.

Intravascular photoacoustics for image-guidance and temperature monitoring during plasmonic photothermal therapy of atherosclerotic plaques: a feasibility study.

Yeager D, Chen YS, Litovsky S, Emelianov S.

Theranostics. 2013 Dec 5;4(1):36-46. doi: 10.7150/thno.7143. eCollection 2013.

14.

Imaging of the vulnerable carotid plaque: biological targeting of inflammation in atherosclerosis using iron oxide particles and MRI.

Chan JM, Monaco C, Wylezinska-Arridge M, Tremoleda JL, Gibbs RG.

Eur J Vasc Endovasc Surg. 2014 May;47(5):462-9. doi: 10.1016/j.ejvs.2014.01.017. Epub 2014 Mar 1.

15.

In vivo visualization of macrophage infiltration and activity in inflammation using magnetic resonance imaging.

Beckmann N, Cannet C, Babin AL, Blé FX, Zurbruegg S, Kneuer R, Dousset V.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2009 May-Jun;1(3):272-98. doi: 10.1002/wnan.16. Review.

PMID:
20049797
16.

New dual mode gadolinium nanoparticle contrast agent for magnetic resonance imaging.

Ghaghada KB, Ravoori M, Sabapathy D, Bankson J, Kundra V, Annapragada A.

PLoS One. 2009 Oct 29;4(10):e7628. doi: 10.1371/journal.pone.0007628.

17.

Gold nanorods-bombesin conjugate as a potential targeted imaging agent for detection of breast cancer.

Heidari Z, Sariri R, Salouti M.

J Photochem Photobiol B. 2014 Jan 5;130:40-6. doi: 10.1016/j.jphotobiol.2013.10.019. Epub 2013 Nov 15.

PMID:
24300991
18.

Detection of hepatocellular carcinoma in transgenic mice by Gd-DTPA- and rhodamine 123-conjugated human serum albumin nanoparticles in T1 magnetic resonance imaging.

Watcharin W, Schmithals C, Pleli T, Köberle V, Korkusuz H, Hübner F, Waidmann O, Zeuzem S, Korf HW, Terfort A, Gelperina S, Vogl TJ, Kreuter J, Piiper A.

J Control Release. 2015 Feb 10;199:63-71. doi: 10.1016/j.jconrel.2014.11.023. Epub 2014 Dec 10.

PMID:
25499552
19.

Enhanced dual contrast agent, Co(2+)-doped NaYF4:Yb(3+),Tm(3+) nanorods, for near infrared-to-near infrared upconversion luminescence and magnetic resonance imaging.

Xia A, Zhang X, Zhang J, Deng Y, Chen Q, Wu S, Huang X, Shen J.

Biomaterials. 2014 Nov;35(33):9167-76. doi: 10.1016/j.biomaterials.2014.07.031. Epub 2014 Aug 6.

PMID:
25108318
20.

Noninvasive detection of macrophage-rich atherosclerotic plaque in hyperlipidemic rabbits using "positive contrast" magnetic resonance imaging.

Korosoglou G, Weiss RG, Kedziorek DA, Walczak P, Gilson WD, Schär M, Sosnovik DE, Kraitchman DL, Boston RC, Bulte JW, Weissleder R, Stuber M.

J Am Coll Cardiol. 2008 Aug 5;52(6):483-91. doi: 10.1016/j.jacc.2008.03.063.

Supplemental Content

Support Center